Newsroom

Strategy and innovation leading the PBM industry

At Prime, our success is determined by our ability to assess the critical role that PBMs play in today's dynamically changing health care landscape; and to respond, with strategy and purpose, to the shifting needs of our clients, employer groups and members.

Follow us in the media and read about the important issues facing us today and what we're doing to address them.

Recent News

Prime Therapeutics responds to FDA approval of Gilead's latest Hepatitis C drug (October 10, 2014)

Duane Barnes, Prime Therapeutics' COO, joins NASP / SPAARx board of directors (October 9, 2014)

Prime Therapeutics, Johns Hopkins publish research on specialty drug copay coupons in "Health Affairs" (October 6, 2014)

Blue Cross Blue Shield Association and Prime Therapeutics study demonstrates health benefits and cost savings of pharmacy benefit integration within insurance plans (October 6, 2014)

Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs (September 30, 2014)

Prime Therapeutics' Wickersham delivers keynote at Managed Markets Summit (September 17, 2014)

Media Release Archive

Access our archive of media releases.

Media Contact

Contact us for more information or with any media queries.

Prime at a Glance

Download our corporate snapshot.

Close